Thus, we conclude that renal ADMA is antifibrotic, which is in line with the conclusion provided by previous in vitro studies or indirect evidence using type I PRMT inhibitors or kidney‐specific deletion of Ddah1 gene in mouse models of renal fibrosis [8, 12]. Here, DDAH1 is linked to renal fibrosis.